Academic literature on the topic '155.930 9596'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '155.930 9596.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "155.930 9596"
1
Hikmi, Nailul, Ridwan Firwandri, and Budi Haryanto. "Penerapan Metoda Job Safety Analysis Dalam Identifikasi Potensi Bahaya Pada Pekerja Divisi Pipa, Sumatera Barat." Jurnal Kesehatan Lingkungan 10, no. 1 (September 13, 2020): 01–07. http://dx.doi.org/10.47718/jkl.v10i1.1090.
Full textAbstract:
Number of work accidents in Kab. Padang Pariaman, West Sumatra in 2012 there were 837 cases of work accidents, in 2013 it increased to 903 cases, in 2014 there were 1050 cases, in 2015 there were a decrease in cases to 956 cases, in 2016 there was an increase in work accident cases to 1535 cases. This study aims to find and prevent potential hazards by identifying hazards, assessing and controlling risks to workers. This study used the JSA method with univariate analysis. The study population was 155 workers with a sample of 112 respondents. This study uses the Jobs Safety Analysis (JSA) sheet by means of observation and interviews and then presents the results of the analysis of the checklist and questionnaire in tabular form. There are two stages of high-risk work with a score of 20 (16-24) in the uncoiling section, two stages of high-risk work with a score of 20 (16-24) in the accumulating section, three high-risk stages with a score of 16 (16-24) in the forming section and sizing, four high-risk stages with a score of 16 (16-24) on the packing section. Risk control is carried out at high risks that produce a large enough impact. It is hoped that the company should carry out risk control in the form of engineering by assembling machines that are safe, productive and efficient.
2
Martelli, Eugenio, Giovanni Sotgiu, Laura Saderi, Massimo Federici, Giuseppe Sangiorgi, Matilde Zamboni, Allegra R. Martelli, et al. "How the First Year of the COVID-19 Pandemic Impacted Patients’ Hospital Admission and Care in the Vascular Surgery Divisions of the Southern Regions of the Italian Peninsula." Journal of Personalized Medicine 12, no. 7 (July 19, 2022): 1170. http://dx.doi.org/10.3390/jpm12071170.
Full textAbstract:
Background: To investigate the effects of the COVID-19 lockdowns on the vasculopathic population. Methods: The Divisions of Vascular Surgery of the southern Italian peninsula joined this multicenter retrospective study. Each received a 13-point questionnaire investigating the hospitalization rate of vascular patients in the first 11 months of the COVID-19 pandemic and in the preceding 11 months. Results: 27 out of 29 Centers were enrolled. April-December 2020 (7092 patients) vs. 2019 (9161 patients): post-EVAR surveillance, hospitalization for Rutherford category 3 peripheral arterial disease, and asymptomatic carotid stenosis revascularization significantly decreased (1484 (16.2%) vs. 1014 (14.3%), p = 0.0009; 1401 (15.29%) vs. 959 (13.52%), p = 0.0006; and 1558 (17.01%) vs. 934 (13.17%), p < 0.0001, respectively), while admissions for revascularization or major amputations for chronic limb-threatening ischemia and urgent revascularization for symptomatic carotid stenosis significantly increased (1204 (16.98%) vs. 1245 (13.59%), p < 0.0001; 355 (5.01%) vs. 358 (3.91%), p = 0.0007; and 153 (2.16%) vs. 140 (1.53%), p = 0.0009, respectively). Conclusions: The suspension of elective procedures during the COVID-19 pandemic caused a significant reduction in post-EVAR surveillance, and in the hospitalization of asymptomatic carotid stenosis revascularization and Rutherford 3 peripheral arterial disease. Consequentially, we observed a significant increase in admissions for urgent revascularization for symptomatic carotid stenosis, as well as for revascularization or major amputations for chronic limb-threatening ischemia.
3
Nawara, A., H. Hirte, and P. Kavsak. "ASSESSING THE FREQUENCY OF CA-125 MEASUREMENTS WITHIN HAMILTON HEALTH SCIENCES AND ST. JOSEPH’S HEALTHCARE." Clinical & Investigative Medicine 32, no. 6S (December 15, 2009): 6. http://dx.doi.org/10.25011/cim.v32i6s.11143.
Full textAbstract:
Objective: To determined if the number and frequency of CA-125 measurements per patient reflect the 2008 NACB (National Academy of Clinical Biochemist) practice guidelines. Methods: We collected data retrospectively on CA-125 over a period of one year as apart of our ongoing practice in monitoring the tumor markers for quality assurance, The number of CA-125 results per patient as well as the time interval between the 1st and 2nd measurements was noted. To enrich this population for the likelihood that the measurement of CA-125 was used for monitoring or for detection of recurrence, we divided the population into patients from the Jurvainski Cancer Centre (JCC) and the rest of the sites. Results: The JCC patients contributed the majority of CA-125 results, representing over 75% of all results (n= 3057 results from 998 patients), whereas the remainder of the sites only yielded 959 results from 920 patients. Further analysis of the JCC patients indicated 2 main subgroups: Group A – patients with 1 or 2 results (n=624 patients); Group B - patients with 3 or more results , Overall, less than 4% of patients at the JCC had a time interval between the 1st and 2nd specimens of less than 2 weeks. Discussion: This initial analysis would indicate that physicians are ordering CA-125 in agreement with the NACB guidelines. To further improve compliance to the guidelines and to prevent subsequent measurements of CA-125 too close, we propose restricting CA-125 orders that are less than 14 days apart to only those that receive Biochemist’s approval.
4
Davies, Michael A., Caroline Robert, Georgina V. Long, Jean Jacques Grob, Keith T. Flaherty, Ana Arance, Vanna Chiarion-Sileni, et al. "COMBI-MB: A phase II study of combination dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600–mutant (mut) melanoma brain metastases (MBM)." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 9506. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.9506.
Full textAbstract:
9506 Background: CNS metastases are common and associated with very poor prognosis in pts with metastatic melanoma (MM). In the phase II BREAK-MB trial, D had clinical activity in BRAF V600–mut MBM. D + T has shown superiority over D alone in pts with BRAF V600–mut mm without MBM; however, efficacy of this regimen on MBM has not been characterized. Here, we report results from a phase II trial of D + T in BRAFV600–mut MBM (COMBI-MB; NCT02039947). Methods: This open-label, phase II study evaluated D 150 mg BID + T 2 mg QD in 4 MBM cohorts: (A) BRAFV600E, asymptomatic MBM, no prior local treatment (Tx); (B) BRAFV600E, asymptomatic MBM, prior local Tx; (C) BRAFV600D/K/R, asymptomatic MBM, with or without prior local Tx; and (D) BRAFV600D/E/K/R, symptomatic MBM, with or without prior local Tx. The primary objective was intracranial response rate (IRR) in cohort A (null hypothesis, IRR ≤ 35%). Secondary endpoints included IRR in cohorts B, C, and D; extracranial (ERR) and overall (ORR) response rates; intracranial (IDCR), extracranial (EDCR), and overall (ODCR) disease control rates; duration of IR, ER, and OR; PFS; OS; and safety. Results: 125 pts were enrolled (A, n = 76; B, n = 16; C, n = 16; D, n = 17). In cohort A, median age was 52, 53% were male, and 37% had LDH > ULN. At data cutoff (28 Nov 2016; median f/u, 9.0 mo), in cohort A, investigator-assessed IRR was 58% (IDCR, 78%), ERR was 55% (EDCR, 80%), and ORR was 58% (ODCR, 80%). Median duration of IR, ER, and OR was 6.5 mo (95% CI, 4.9-10.3), 10.2 mo (95% CI, 6.5-13.0), and 6.5 mo (95% CI, 4.9-10.3), respectively. Median PFS was 5.6 mo (95% CI, 5.3-7.4). Independent review supported these results. 6-mo OS was 79%; with 31 pts (41%) still in f/u, preliminary median OS was 10.8 mo (95% CI, 8.7-19.6). Efficacy in cohorts B, C, and D will be reported. AEs across cohorts (any, 98%; grade 3/4, 48%) were consistent with prior D + T studies; 10% of pts (8% in cohort A) discontinued due to AEs. Conclusions: In this first report of a phase II trial evaluating a BRAF and MEK inhibitor combination in BRAFV600–mut MBM, the primary endpoint was met. Promising IRR and IDCR were seen with D + T, but responses appear less durable than reported for mm without MBMs. No unexpected safety issues were observed. Clinical trial information: NCT02039947.
5
Bakkar, M. N., S. M. Basmaeil, and A. A. Hamam. "Meat production and quality two unique properties of young camels." Revue d’élevage et de médecine vétérinaire des pays tropicaux 53, no. 2 (February 1, 2000): 218. http://dx.doi.org/10.19182/remvt.9756.
Full textAbstract:
(texte complet en anglais)Eighteen one-hump black (Majaheem) young camels were used to study growth rate and carcass percentage. The animals were selected and bought of similar age (about six months) and weight (around 150 kg). They were assigned randomly into three feeding groups. Each group was fed two types of rations: (A) concentrated pellets 18% crude protein at the rate of 1.5% CWT; and (B) one of three types of roughage: (a) alfalfa hay, (b) Rhodes grass hay, or (c) wheat straw treated with ammonia gas. Roughage was weighed and fed ad libitum. The experiment was ended when anirnals were about 14 months of age. Average body weights were 315, 298.8 and 291.4 kg for the three groups, respectively. Average daily gains for the three respective groups were 932, 803 and 767 g per day. Average carcass weights/kg (and carcass percentages) of each group were 180.6 (57.3%) for alfalfa, 170.7 (57.1%) for Rhodes and 168.1 (57.7%) for treated straw. Average forequarters weights/kg (and percentages to the carcass) were 98.9 (54.8%), 95.6 (56%) and 88.1 (52.4%) for the three groups, respectively. The hindquarters average weights/kg (and percentages) for the three respective groups were: 81,7 (45.2%), 75.1 (44%) and 80 (47.6%). Eight-year records (1986-1994) on carcasses of carnels, cattle and sheep were obtained from Riyadh Modem Slaughterhouse. The total number of animals killed was 3,891,301. Comparisons were made between the number of anirnals killed and the number of carcasses destroyed for each of the three species. It was found that on average for every carnel carcass destroyed 12 carcasses of cattle and 19 carcasses of sheep were destroyed. These results show clearly that camels produce the most hygienic meat for human consumption in comparison with cattle and sheep.
6
Garcés B., Humberto, Ana Batista Batista, and Natasha Sánchez. "CARACTERIZACIÓN DE SITIOS DE ANIDACIÓN DE TORTUGAS MARINAS EN PLAYA LAGARTO, PEDASÍ, PROVINCIA DE LOS SANTOS, PANAMÁ." Tecnociencia 22, no. 2 (July 2, 2020): 259–77. http://dx.doi.org/10.48204/j.tecno.v22n2a14.
Full textAbstract:
Las tortugas marinas son reptiles de gran antigüedad, habitan la tierra desde más de 110 millones de años, estas especies se encuentran amenazadas por el incremento de las actividades antropogénicas. El propósito fue corroborar la importancia de playa Lagarto como sitio de anidación de tortugas marinas y determinar los principales factores antropogénicos que las afectan. La toma de datos comprendió agosto 2016 a febrero 2017, se midieron humedad, granulometría y contenido orgánico, y censos de hembras, rastros y nidos. Se obtuvo un mayor contenido orgánico (15.5 %) y humedad (9.0 %) en la zona alta donde ocurrió la mayor anidación, con predominancia de arena fina (0.125 mm) con 52.5 % y mediana (0.250 mm) con 39 % del total. Se identificó la tortuga lora (Lepidochelys olivacea) con 11 nidos y 1 013 huevos y la tortuga verde (Chelonia mydas) con cuatro nidos y 398 huevos. La tortuga lora obtuvo un promedio de 66.2 LCC, 66.9 ACC, 75.6 HE y 43.4 HI, mientas que la tortuga verde con 95.6 LCC, 88.4 ACC, 94.0 HE y 47.9 HI. Se determinó que las principales actividades antropogénicas fueron la extracción ilegal de huevos, la urbanización costera y la contaminación sólida.
7
Dejenie Habtewold, Tesfa, Yosef Tsige Radie, and Nigussie Tadesse Sharew. "Prevalence of Depression among Type 2 Diabetic Outpatients in Black Lion General Specialized Hospital, Addis Ababa, Ethiopia." Depression Research and Treatment 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/184902.
Full textAbstract:
Background.The emotional consequences of diabetes have been scrutinized by a number of investigative teams and there are varying reports about the association of depression with type 2 diabetes mellitus. However, there is limited data about this in Ethiopia. Therefore, the purpose of this study was to assess the prevalence of comorbid depression among type 2 diabetic outpatients.Methods and Materials.Institution based cross-sectional study design was conducted on a random sample of 276 type 2 diabetic outpatients from Black Lion General Specialized Hospital. Systematic random sampling technique was used to get these individual patients from 920 type 2 diabetic outpatients who have an appointment during the data collection period. Patients’ depression status was measured using Patient Health Questionnaire 9 (PHQ 9).Result.Totally 264 type 2 diabetic outpatients were interviewed with a response rate of 95.6%. The prevalence of depression among type 2 diabetic outpatients was 13%. Based on PHQ 9 score, 28.4% (75) fulfilled the criteria for mild depression, 12.1% (32) for moderate depression, 2.7% (7) for moderately severe depression, and 1.5% (4) for severe depression. But 45.8% (121) of patients had no clinically significant depression.Conclusion.This study demonstrated that depression is a common comorbid health problem in type 2 diabetic outpatients with a prevalence rate of 13%.
8
Clark, Catherine, Lois M. Ednie, Gengrong Lin, Kathy Smith, Klaudia Kosowska-Shick, Pamela McGhee, Bonifacio Dewasse, et al. "Antistaphylococcal Activity of Dihydrophthalazine Antifolates, a Family of Novel Antibacterial Drugs." Antimicrobial Agents and Chemotherapy 53, no. 4 (February 2, 2009): 1353–61. http://dx.doi.org/10.1128/aac.01619-08.
Full textAbstract:
ABSTRACT For a panel of 153 Staphylococcus aureus clinical isolates (including 13 vancomycin-intermediate or heterogeneous vancomycin-intermediate and 4 vancomycin-resistant strains), MIC50s and MIC90s of three novel dihydrophthalazine antifolates, BAL0030543, BAL0030544, and BAL0030545, were 0.03 and 0.25 μg/ml, respectively, for methicillin-susceptible strains and 0.03 and ≤0.25 μg/ml, respectively, for methicillin-resistant strains. For a panel of 160 coagulase-negative staphylococci (including 5 vancomycin-intermediate and heterogeneous vancomycin-intermediate strains and 7 linezolid-nonsusceptible strains), MIC50s and MIC90s were ≤0.03 and ≤0.06 μg/ml, respectively, for methicillin-susceptible strains and 0.06 and 0.5 μg/ml, respectively, for methicillin-resistant strains. Vancomycin was active against 93.0% of 313 staphylococci examined; linezolid was active against all S. aureus strains and 95.6% of coagulase-negative staphylococcus strains, whereas elevated MICs of clindamycin, minocycline, trimethoprim, and rifampin for some strains were observed. At 4× MIC, the dihydrophthalazines were bactericidal against 11 of 12 staphylococcal strains surveyed. The prolonged serial passage of some staphylococcal strains in the presence of subinhibitory concentrations of BAL0030543, BAL0030544, and BAL0030545 produced clones for which dihydrophthalazines showed high MICs (>128 μg/ml), although rates of endogenous resistance development were much lower for the dihydrophthalazines than for trimethoprim. Single-step platings of naïve staphylococci onto media containing dihydrophthalazine antifolates indicated considerable variability among strains with respect to preexistent subpopulations nonsusceptible to dihydrophthalazine antifolates.
9
Liao, Chia-Te, Han Siong Toh, Li Sun, Chun-Ting Yang, Angie Hu, Dongmei Wei, Jesus Melgarejo, and Zhen-Yu Zhang. "Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension." JAMA Network Open 6, no. 2 (February 27, 2023): e230708. http://dx.doi.org/10.1001/jamanetworkopen.2023.0708.
Full textAbstract:
ImportanceOlder patients with hypertension receiving intensive systolic blood pressure control (110-130 mm Hg) have lower incidences of cardiovascular events than those receiving standard control (130-150 mm Hg). Nevertheless, the mortality reduction is insignificant, and intensive blood pressure management results in more medical costs from treatments and subsequent adverse events.ObjectiveTo examine the incremental lifetime outcomes, costs, and cost-effectiveness of intensive vs standard blood pressure control in older patients with hypertension from the health care payer’s perspective.Design, Setting, and ParticipantsThis economic analysis was conducted with a Markov model to examine the cost-effectiveness of intensive blood pressure management among patients aged 60 to 80 years with hypertension. Treatment outcome data from the Trial of Intensive Blood-Pressure Control in Older Patients With Hypertension (STEP trial) and different cardiovascular risk assessment models for a hypothetical cohort of STEP-eligible patients were used. Costs and utilities were obtained from published sources. The incremental cost-effectiveness ratio (ICER) against the willingness-to-pay threshold was used to evaluate whether the management was cost-effective. Extensive sensitivity, subgroup, and scenario analyses were performed to address uncertainty. The US and UK population using race-specific cardiovascular risk models were conducted in the generalizability analysis. Data for the STEP trial were collected from February 10 to March 10, 2022, and were analyzed for the present study from March 10 to May 15, 2022.InterventionsHypertension treatments with a systolic blood pressure target of 110 to 130 mm Hg or 130 to 150 mm Hg.Main Outcomes and MeasuresIncremental lifetime quality-adjusted life-years (QALYs), costs, and ICER are discounted at the given rates annually.ResultsAfter simulating 10 000 STEP-eligible patients assumed to be 66 years of age (4650 men [46.5%] and 5350 women [53.5%]) in the model, the ICER values were ¥51 675 ($12 362) per QALY gained in China, $25 417 per QALY gained in the US, and £4679 ($7004) per QALY gained in the UK. Simulations projected that the intensive management in China being cost-effective were 94.3% and 100% below the willingness-to-pay thresholds of 1 time (¥89 300 [$21 364]/QALY) and 3 times (¥267 900 [$64 090]/QALY) the gross domestic product per capita, respectively. The US had 86.9% and 95.6% probabilities of cost-effectiveness at $50 000/QALY and $100 000/QALY, respectively, and the UK had 99.1% and 100% of probabilities of cost-effectiveness at £20 000 ($29 940)/QALY and £30 000 ($44 910)/QALY, respectively.Conclusions and RelevanceIn this economic evaluation, the intensive systolic blood pressure control in older patients produced fewer cardiovascular events and had acceptable costs per QALY gained, well below the typical willingness-to-pay thresholds. The cost-effective advantages of intensive blood pressure management in older patients were consistent over various clinical scenarios across different countries.
10
Cheung, Yin Ting, Maung Shwe Ham Guo, Yuan Chuan Kee, Wai Keung Chui, Han Kiat Ho, Gilbert Fan, Wei Sean Yong, et al. "Association of pro-inflammatory biomarkers and post-chemotherapy cognitive changes in Asian breast cancer patients: A prospective cohort study." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 9506. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9506.
Full textAbstract:
9506 Background: Although existing evidence suggests that cytokines play an intermediary role in the development of post-chemotherapy cognitive changes, specific cytokines associated with this neurotoxic sequela of chemotherapy are still unknown. This study was designed to identify pro-inflammatory biomarkers that are associated with memory and attention impairment in Asian patients receiving chemotherapy. Methods: This is a prospective, cohort study conducted at the National Cancer Centre Singapore. Early-stage Asian breast cancer patients (Stage I to III), who received anthracycline and/or taxane-based chemotherapy were recruited. Computerized neuropsychological assessments (Headminder) were administered to evaluate patients’ memory and attention performances and a panel of pro-inflammatory plasma cytokines (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, GM-CSF, IFN-γ and TNF-α) was evaluated using multiplex immunoassay at three time points: prior to chemotherapy (T1), at midpoint (T2), and end of chemotherapy (T3). Memory and attention impairment were defined as a >2.5 reduction of the Zscore from baseline, as calculated by the reliable change index for repeated cognitive measurements. Results: Thirty-six patients were included (mean age 49.7±9.0 years; 80.6% Chinese). Comparing to T1, 50.0% and 36.1% of the patients suffered memory and attention impairment at T3, respectively. Comparing patients with intact memory to those who suffered impairment from T2 to T3, they had higher levels of circulating IL-1β [median (IQR): 0.44 (0.1-0.5) vs 0.56 (0.4-0.7) pg/ml, p=0.069], IL-4 [0.41 (0.0-0.8) vs 0.85 (0.2-1.5) pg/ml, p=0.067) and TNF-α [1.78 (1.3-2.2) vs 3.01 (1.3-3.5) pg/ml, p=0.069]. At T3, reduction of attention scores were associated with higher levels of IL-1β (rs= -0.37, p=0.023) and IL-6 (rs= -0.33, p=0.045). No significant associations were identified with IL-2, IL-8, IL-10, GM-CSF and IFN-γ. Conclusions: These findings suggest that an increase in the post-chemotherapy levels of TNF-α, IL-1β, IL-4 and IL-6 may have an association with the manifestations of memory and attention impairment in Asian breast cancer patients.
Dissertations / Theses on the topic "155.930 9596"
1
Geall, Edward. "The palatinate of Durham and the Tudor state, c. 1485-1558." Thesis, University of Warwick, 2016. http://wrap.warwick.ac.uk/95896/.
Full textAbstract:
This thesis is an examination of several local families and their role shaping the palatinate of Durham’s position within the early Tudor state. Histories of the late medieval and early Tudor bishopric have tended to treat the palatinate as either an intractable obstacle to the consolidation of the English state, or as a highly distinctive and autonomous seat of power in the North-East, free from any meaningful encroachment by the crown. This thesis reframes Durham within the wider context of advancements in the early Tudor state and, particularly, more recent discussions on the nature and efficacy of patron-client or patronage networks. The central themes of this thesis are threefold. First, rather than see the history of Durham, its bishops, and landowners as a pitched battle against crown intervention, this thesis posits a new interpretation, one which foregrounds cooperation and mutual benefit. Early Tudor attitudes towards Durham were, for the most part, not grounded on a desire to abolish or undermine the bishopric and its political and administrative infrastructure. Where Durham’s resources could be applied for the betterment of the national polity, successive governments sought to work with, not against, the region’s landowners and officers, who in turn realised the benefits to be had from forging contacts with the court and other senior royal officials. Second, this increasingly pragmatic stance was nurtured through the formation and consolidation of patronage networks. It was through these symbiotic networks that both the crown and local landowners changed the nature of the bishopric’s role within the national polity; much like neighbouring Yorkshire, patron-client networks had the effect of bringing Durham more closely into line with central government, but not necessarily to the detriment of local customs and ideas of government. Finally, by examining the role of local landowners from outside the bishopric, in conjunction with Durham’s leading families and the bishops’ episcopal households, this thesis argues that the palatinate formed part of what was a highly effective regional community.
Book chapters on the topic "155.930 9596"
1
Guernet, C. "Neogene and Pleistocene ostracodes, Sites 959 and 960, Gulf of Guinea." In Proceedings of the Ocean Drilling Program, 159 Scientific Results. Ocean Drilling Program, 1998. http://dx.doi.org/10.2973/odp.proc.sr.159.019.1998.
Full text
2
Masure, E., R. Rauscher, J. Dejax, M. Schuler, and B. Ferré. "CretaceousPaleocene palynology from the Côte d'Ivoire-Ghana Transform Margin, Sites 959, 960, 961, and 962." In Proceedings of the Ocean Drilling Program, 159 Scientific Results. Ocean Drilling Program, 1998. http://dx.doi.org/10.2973/odp.proc.sr.159.040.1998.
Full text
3
Clift, P. D., A. Carter, and A. J. Hurford. "Apatite fission track analysis of Sites 959 and 960 on the Transform Continental Margin of Ghana, West Africa." In Proceedings of the Ocean Drilling Program, 159 Scientific Results. Ocean Drilling Program, 1998. http://dx.doi.org/10.2973/odp.proc.sr.159.004.1998.
Full text
4
Marks II, Robert J. "Signal Recovery." In Handbook of Fourier Analysis & Its Applications. Oxford University Press, 2009. http://dx.doi.org/10.1093/oso/9780195335927.003.0015.
Full textAbstract:
The literature on the recovery of signals and images is vast (e.g., [23, 110, 112, 257, 391, 439, 791, 795, 933, 934, 937, 945, 956, 1104, 1324, 1494, 1495, 1551]). In this Chapter, the specific problem of recovering lost signal intervals from the remaining known portion of the signal is considered. Signal recovery is also a topic of Chapter 11 on POCS. To this point, sampling has been discrete. Bandlimited signals, we will show, can also be recovered from continuous samples. Our definition of continuous sampling is best presented by illustration.Asignal, f (t), is shown in Figure 10.1a, along with some possible continuous samples. Regaining f (t) from knowledge of ge(t) = f (t)Π(t/T) in Figure 10.1b is the extrapolation problem which has applications in a number of fields. In optics, for example, extrapolation in the frequency domain is termed super resolution [2, 40, 367, 444, 500, 523, 641, 720, 864, 1016, 1099, 1117]. Reconstructing f (t) from its tails [i.e., gi(t) = f (t){1 − Π(t/T)}] is the interval interpolation problem. Prediction, shown in Figure 10.1d, is the problem of recovering a signal with knowledge of that signal only for negative time. Lastly, illustrated in Figure 10.1e, is periodic continuous sampling. Here, the signal is known in sections periodically spaced at intervals of T. The duty cycle is α. Reconstruction of f (t) from this data includes a number of important reconstruction problems as special cases. (a) By keeping αT constant, we can approach the extrapolation problem by letting T go to ∞. (b) Redefine the origin in Figure 10.1e to be centered in a zero interval. Under the same assumption as (a), we can similarly approach the interpolation problem. (c) Redefine the origin as in (b). Then the interpolation problem can be solved by discarding data to make it periodically sampled. (d) Keep T constant and let α → 0. The result is reconstructing f (t) from discrete samples as discussed in Chapter 5. Indeed, this model has been used to derive the sampling theorem [246]. Figures 10.1b-e all illustrate continuously sampled versions of f (t).
5
"Part B Commentary, 6 Delegated Acts and Implementing Acts, Art.35: Exercise of the delegation." In Market Abuse Regulation, edited by Ventoruzzo Marco. Oxford University Press, 2022. http://dx.doi.org/10.1093/law/9780198871095.003.0043.
Full textAbstract:
This chapter turns to the subject matter of Article 35. This Article sets out the power to adopt delegated and implementing acts to the Commission. It also refers to previous Articles which have a bearing on Article 35 and the rules of delegation. So far, the Commission has adopted seventeen acts from December 2015 to October 2020. These are: the Commission Delegated Regulation (EU) 2016/522; the Commission Implementing Directive (EU) 2015/2392; the Commission Delegated Regulation (EU) 2016/908; the Commission Delegated Regulation (EU) 2016/909; the Commission Delegated Regulation (EU) No 2016/1052; the Commission Delegated Regulation (EU) 2016/957; the Commission Delegated Regulation (EU) 2016/958; the Commission Implementing Regulation (EU) 2016/347; the Commission Implementing Regulation (EU) 2016/523; the Commission Implementing Regulation (EU) 2016/378; the Commission Implementing Regulation (EU) 2016/959; the Commission Delegated Regulation (EU) 2016/960; the Commission Implementing Regulation (EU) 2016/1055; the Commission Implementing Regulation (EU) 2017/1158; the Commission Implementing Regulation (EU) 2018/292; the Commission Delegated Regulation (EU) 2019/461; and the Commission Implementing Regulation (EU) 2020/1406.